Heartflow Inc
NASDAQ:HTFL
Heartflow Inc
Stock-Based Compensation
Heartflow Inc
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Heartflow Inc
NASDAQ:HTFL
|
Stock-Based Compensation
10.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Stock-Based Compensation
$130.3m
|
CAGR 3-Years
36%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Stock-Based Compensation
$72.4m
|
CAGR 3-Years
32%
|
CAGR 5-Years
98%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Stock-Based Compensation
$44.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
12%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Stock-Based Compensation
$42.1m
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Heartflow Inc
Glance View
Heartflow Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Mountain View, California. The company went IPO on 2025-08-08. HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
See Also
What is Heartflow Inc's Stock-Based Compensation?
Stock-Based Compensation
10.2m
Based on the financial report for Dec 31, 2024, Heartflow Inc's Stock-Based Compensation amounts to 10.2m .
What is Heartflow Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 1Y
-14%
Over the last year, the Stock-Based Compensation growth was -14%.
